NCT02167802View on ClinicalTrials.gov

Construction and Validation of a Tool for Automatic Identification of Care Pathways At Risk of Sub-optimality in the Management of Severe Infections in Children (DIABACT IV)

CompletedOBSERVATIONAL

Enrollment

524

Participants

Timeline

Start Date

March 20, 2015

Primary Completion Date

March 7, 2020

Study Completion Date

March 7, 2020

Conditions

Severe Infection

Trial Locations (12)

75

AP-HP, Paris

29609

Jacques Sizun, Brest

33076

Olivier Brissaud, Bordeaux

34295

Gilles Cambonie, Montpellier

38043

Thierry Debillon, Grenoble

42055

Hugues Patural, Saint-Etienne

44093

Elise Launay, Nantes

49933

Angers University Hospital, Angers

59037

Stéphane Leteurtre, Lille

69003

Etienne Javouhey, Lyon

75000

Stéphane Dauger, Paris

Sylvain Renolleau, Paris

All Listed Sponsors

lead

Nantes University Hospital

OTHER

NCT02167802 - Construction and Validation of a Tool for Automatic Identification of Care Pathways At Risk of Sub-optimality in the Management of Severe Infections in Children (DIABACT IV) | Biotech Hunter | Biotech Hunter